Investor Dossier
ATEM Capital Fund LP
active
Typeinvestor
Location—
Portfolio (2 investments)
Amolyt Pharma
Series B · Sept 2021
€68.0M
Amolyt Pharma
Series C · Jan 2023
€128.1M
Investor Dossier
Series B · Sept 2021
€68.0M
Series C · Jan 2023
€128.1M